In the NIHB program, specific diabetes medication coverage is more extensive than in the formulary list that was the backgrounder list that was circulated. There are some disparities between the NIHB list and the Canadian practice guidelines that are published. They're not all-inclusive and comprehensive in the first place, if we really wanted to pick them apart, but they are better than the formulary list that was proposed here as a base minimum. There are some that are covered only if specific requirements are met, such as being an insulin user to get a specific medication covered.
It varies in terms of all of the medications. One big one that we see that is not included is GLP-1s. That's something that our indigenous people use extensively to manage their blood sugars in a way that works for them.
I think that we need to look very holistically on what it also provides outside of pharmacological care, because pharmacological care is only a certain portion of what is covered under non-insured health benefits.